- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Consumer Discretionary
Swiss Pharmaceuticals & Biotech Consumer Discretionary
UPDATED Mar 11, 2024
All the companies in the consumer discretionary sector including household durables, leisure products and luxury goods.
24 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ROGRoche Holding | CHF242.00 | 3.6% | -8.4% | CHF194.4b | CHF282.94 | PE16.8x | E8.4% | 4.0% | ||
| NOVNNovartis | CHF88.80 | -1.5% | 18.8% | CHF181.5b | CHF95.99 | PE24.1x | E9.2% | 3.7% | ||
| LONNLonza Group | CHF458.20 | -1.1% | -12.9% | CHF34.0b | CHF515.24 | PE52x | E18.7% | 0.9% | ||
| SDZSandoz Group | CHF27.84 | -2.0% | n/a | CHF12.0b | CHF33.59 | PE22.3x | E19.7% | n/a | ||
| BANBBachem Holding | CHF81.90 | 16.4% | -1.4% | CHF6.1b | CHF71.17 | PE54.9x | E20.0% | 1.0% | ||
| TECNTecan Group | CHF367.60 | 4.7% | -1.0% | CHF4.7b | CHF390.86 | PE43.2x | E12.2% | 0.8% | ||
| SFZNSiegfried Holding | CHF921.50 | -0.8% | 41.1% | CHF3.9b | CHF993.55 | PE34.7x | E14.5% | 0.4% | ||
| DESNDottikon ES Holding | CHF235.50 | -1.9% | -9.4% | CHF3.2b | n/a | PE37.7x | S11.2% | 0% | ||
| SKANSKAN Group | CHF78.20 | -5.7% | 18.3% | CHF1.8b | CHF91.33 | PE64.3x | E22.9% | 0.3% | ||
| COPNCosmo Pharmaceuticals | CHF67.50 | 0% | 18.6% | CHF1.1b | CHF75.96 | PE104.4x | E36.9% | 1.5% | ||
| PPGNPolyPeptide Group | CHF17.02 | 6.7% | -26.4% | CHF560.7m | CHF18.76 | PS2.1x | E66.7% | 0% | ||
| BSLNBasilea Pharmaceutica | CHF38.25 | 7.3% | -23.5% | CHF459.1m | CHF69.08 | PE43.9x | E33.2% | 0% | ||
| IDIAIdorsia | CHF1.91 | 7.6% | -84.1% | CHF340.2m | CHF2.07 | PS1.8x | E17.4% | n/a | ||
| XLSXlife Sciences | CHF47.20 | 17.4% | 50.8% | CHF269.2m | CHF68.00 | PE16.7x | E-142.7% | n/a | ||
| KURNKuros Biosciences | CHF5.36 | 0% | 252.6% | CHF197.4m | n/a | PS9.7x | n/a | n/a | ||
| NWRNNewron Pharmaceuticals | CHF8.38 | 2.4% | 56.3% | CHF149.8m | CHF11.34 | PS17.8x | E51.0% | n/a | ||
| MOLNMolecular Partners | CHF3.69 | -0.9% | -36.4% | CHF121.1m | CHF9.50 | PS13.9x | E1.7% | n/a | ||
| SANNSanthera Pharmaceuticals Holding | CHF9.95 | -3.6% | 44.6% | CHF91.7m | CHF30.00 | PS17.8x | S149.8% | n/a | ||
| RLFRelief Therapeutics Holding | CHF1.45 | 0% | -81.3% | CHF18.2m | n/a | PS3.1x | n/a | n/a | ||
| ADXNAddex Therapeutics | CHF0.08 | 25.0% | -63.2% | CHF11.2m | n/a | PS5.5x | E8.3% | n/a | ||
| SPEXSpexis | CHF0.13 | -12.2% | -69.0% | CHF8.8m | n/a | PS7.5x | n/a | n/a | ||
| KNRSKinarus Therapeutics Holding | CHF0.0052 | -3.7% | -62.9% | CHF5.6m | n/a | n/a | n/a | n/a | ||
| OBSNObsEva | CHF0.017 | 6.3% | -87.8% | CHF2.0m | n/a | PE0.3x | n/a | n/a | ||
| ACHIAchiko | CHF0.0004 | 0% | -98.9% | CHF58.1k | n/a | PS2.6x | n/a | n/a |
Page 1 of 1